Systems-based pharmacogenomics reveals that the ubiquitin ligase SCF-SKP2 is a molecular determinant of clinical response to bortezomib-based therapy

Systems-based pharmacogenomics reveals that the ubiquitin ligase SCF-SKP2 is a molecular determinant of clinical response to bortezomib-based therapy

Research Abstract
NULL
Research Authors
Ehsan Malek, Mohamed A. Y. Abdel-Malek, James J. Driscoll
Research Department
Department of Clinical Pathology
Research Journal
ACR Annual Meeting 2015, Philadelphia, Pennsylvania, USA
Research Member
Mohamed Ahmed Yehya Abdel-Malek
Research Pages
NULL
Research Publisher
NULL
Research Rank
3
Research Vol
NULL
Research Website
NULL
Research Year
2015